Literature DB >> 2781528

Absence of components of coagulation and fibrinolysis pathways in situ in mesothelioma.

M Z Wojtukiewicz1, L R Zacharski, V A Memoli, W Kisiel, B J Kudryk, S M Rousseau, D C Stump.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2781528     DOI： 10.1016/0049-3848(89)90445-3

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  7 in total

Review 1.  Non-tissue factor procoagulants in cancer cells.

Authors:  S G Gordon; M Chelladurai
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

2.  Identification of human plasma proteins as major clients for the extracellular chaperone clusterin.

Authors:  Amy R Wyatt; Mark R Wilson
Journal:  J Biol Chem       Date:  2009-12-07       Impact factor: 5.157

3.  Acute phase proteins are major clients for the chaperone action of α₂-macroglobulin in human plasma.

Authors:  Amy R Wyatt; Nathan W Zammit; Mark R Wilson
Journal:  Cell Stress Chaperones       Date:  2012-08-16       Impact factor: 3.667

Review 4.  The role of fibrin in tumor metastasis.

Authors:  V Costantini; L R Zacharski
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

5.  Chemotherapy management of malignant pleural mesothelioma: a phase II study comparing two popular chemotherapy regimens.

Authors:  E E Habib; E S Fahmy
Journal:  Clin Transl Oncol       Date:  2013-02-14       Impact factor: 3.405

6.  Regulation of fibrin deposition by malignant mesothelioma.

Authors:  S Idell; S Pueblitz; S Emri; Y Gungen; L Gray; A Kumar; D Holiday; K B Koenig; A R Johnson
Journal:  Am J Pathol       Date:  1995-11       Impact factor: 4.307

7.  Subventricular zone involvement in Glioblastoma - A proteomic evaluation and clinicoradiological correlation.

Authors:  Kishore Gollapalli; Saicharan Ghantasala; Sachendra Kumar; Rajneesh Srivastava; Srikanth Rapole; Aliasgar Moiyadi; Sridhar Epari; Sanjeeva Srivastava
Journal:  Sci Rep       Date:  2017-05-03       Impact factor: 4.379
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.